This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit

Pneumococcal Immunization Masterclass: Taking Action, Protecting Patients



Time to Complete

1.25 hours


July 31, 2019


July 31, 2020
Add to Queue

Maximum Credits

1.25 / AMA PRA Category 1 CreditsTM
1.25 / ABIM MOC Part II Points

Accredited Provider

Jointly provided by Postgraduate Institute for Medicine and Miller Medical Communications, LLC.

Commercial Supporter

This activity is supported by an independent educational grant provided by Merck & Co.

Program Description

The importance of vaccinating at-risk adults against pneumococcal disease cannot be overstated. Each year thousands die unnecessarily as the result of pneumococcal infections. However, despite the Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) guidelines recommending immunization of these populations, vaccination rates remain less than optimal, particularly among younger adults who are at risk for the disease. This activity addresses strategies for implementing the recommendations and increasing coverage in eligible individuals.

Intended Audience

This activity is intended for internal medicine and family physicians engaged in the care of providing patients with pneumococcal immunization.

Educational Objectives

After completing this activity, participants should be better able to:

  • Summarize the burden of vaccine-preventable disease
  • Implement ACIP recommendations for administration of pneumococcal vaccines in adults
  • Explain the importance of vaccinating at-risk adults to prevent pneumococcal disease, and make a strong recommendation for pneumococcal immunization to all eligible individuals

Conflicts of Interest Disclosure Policy

The Postgraduate Institute for Medicine requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


Robert H. Hopkins, Jr., MD, MACP, FAAP (Program Chair)
Professor of Internal Medicine and Pediatrics
University of Arkansas for Medical Sciences
College of Medicine
Chief, Division of General Internal Medicine
University of Arkansas for Medical Sciences Hospital
Little Rock, Arkansas

Dr. Hopkins discloses the following:
Salary: UAMS College of Medicine
Other, Federal Committee Service: US Dept. of Health and Human Service (NVAC Chair)

Lawrence Herman, MPA, PA-C, DFAAPA
Adjunct Professor
School of Medicine, Physician Assistant Program
The University of Texas Medical Branch
Palantir Healthcare, LLC
Boiling Springs, South Carolina

Mr. Herman discloses the following:
Consulting Fees: NOVO Nordisk
Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: NOVO Nordisk

Associate Professor of Family & Community Medicine
Lewis Katz School of Medicine at Temple University
Department Chair, Family & Community Medicine
Temple University Hospital & Lewis Katz School of Medicine at Temple University
Philadelphia, Pennsylvania

Dr. Savoy discloses the following:
Salary: Temple University/Temple Health
Other: Faculty for AAFP Courses, American Academy Of Family Physicians; Author, Merck Manual (Chapter On HPV)

Planners and Managers

The PIM planners and managers have nothing to disclose.

The Miller Medical Communications, LLC, planners and managers have nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Miller Medical Communications, LLC.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points [and patient safety MOC credit] in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.




There are no fees for participating and receiving CME/CE credit for this activity. During the period July 31, 2019 through July 31, 2020, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon successfully completing the post-test with a score of 75% or better and the activity evaluation, your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

Contact Information for Questions About the Activity:
Kerri Leonard,, 212-661-7400, ext. 9

If you have any questions relating to the accreditation of this activity, please contact Postgraduate Institute for Medicine at: or (303) 799-1930.

Privacy Policy

Postgraduate Institute for Medicine Privacy Policy

Miller Medical Communications, LLC- Kerri Leonard,, 212-661-7400, ext. 9

myCME privacy policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue